TL;DR — 2026 Healthcare Practice Multiples
- Physical therapy: 4.0–6.5x EBITDA (multi-site with documented referral diversity at the top)
- Behavioral health / mental health: 5.0–9.0x EBITDA (commercial payer mix is the decisive variable)
- Home health / home care agencies: 5.5–8.5x EBITDA (Medicare-certified skilled nursing agencies at the high end)
- Urgent care centers: 5.0–8.0x EBITDA (multi-site operators with insurance acceptance at the top)
- Primary care / physician group: 3.5–6.5x EBITDA (W-2 physician employment agreements lift the multiple)
- Payer mix is the single strongest multiple driver across all sub-types
- Physician employment structure (W-2 vs. 1099) is the primary risk buyers price post-close
Healthcare practice multiples by sub-type: summary table
These are indicative lower-middle-market ranges for practices with $1M–$15M EBITDA. Multiples above $25M EBITDA can exceed these ranges when competitive PE processes develop. All figures assume commercial payer mix above 40%; Medicare-heavy or Medicaid-primary practices land at or below the low end of each range.
| Sub-type | EBITDA Multiple | Revenue Multiple | Typical Timeline | Primary Buyers |
|---|---|---|---|---|
| Physical therapy | 4.0–6.5x | 0.9–1.5x | 6–9 months | PE platform Health system Individual PT operator |
| Behavioral health / mental health | 5.0–9.0x | 1.0–2.0x | 6–10 months | PE roll-up Behavioral health platform Health system |
| Home health / home care agency | 5.5–8.5x | 0.6–1.2x | 7–10 months | PE platform National home health chain Health system |
| Urgent care center | 5.0–8.0x | 0.9–1.6x | 5–9 months | Urgent care chain PE roll-up Health system |
| Primary care / physician group | 3.5–6.5x | 0.5–1.0x | 6–10 months | PE MSO platform Health system Physician group |
These ranges reflect the lower-middle market (practices with $1M–$15M EBITDA). A PE platform adding a practice to an existing portfolio in the same geography routinely pays above the top of the indicative range to justify the operational integration costs. The multiple you receive depends heavily on whether a competitive process surfaces a platform buyer already operating in your market. See the guide to healthcare M&A advisors for firms that specialize in each sub-type and run structured processes to surface that competition.
Physical therapy: 4.0–6.5x EBITDA
Physical therapy practices
Physical therapy is one of the most actively consolidated healthcare sub-sectors. PE platforms have built national footprints through serial acquisition of independent PT practices, driving a disciplined acquisition market with well-established valuation benchmarks. The range reflects real differences in practice quality, not buyer hesitation.
Practices at the high end (5.5–6.5x EBITDA) share three characteristics: multiple locations with documented referral diversity across at least 5 or more orthopedic and sports medicine sources, a staff of employed W-2 therapists with signed non-compete agreements, and EBITDA margins above 18%. The referral diversity metric is important because a single-source orthopedic referral relationship is considered non-transferable if that surgeon retires or redirects volume; buyers price that risk directly.
Single-location practices or owner-operators who are themselves the primary treating therapist land at 3.5–4.5x EBITDA because the revenue is partially tied to the departing owner. Practices in Medicare Advantage-heavy markets also compress toward the low end, as MA rate risk is harder for buyers to underwrite than a diversified commercial payer contract portfolio. Physical therapy practices in states with tight certificate of need requirements for additional locations trade at modest premiums because the regulatory barrier to entry protects the existing patient census.
Behavioral health and mental health: 5.0–9.0x EBITDA
Behavioral health and mental health practices
Behavioral health is the highest-multiple sub-type in healthcare practice M&A in 2026 and has been the fastest-growing healthcare M&A category for three consecutive years. PE acquisition volume in behavioral health accelerated substantially following the mental health parity enforcement improvements under the No Surprises Act and expanded telehealth reimbursement, which improved commercial payer penetration for outpatient mental health services that were historically self-pay or out-of-network.
Practices at the top of the range (7.5–9.0x EBITDA) are multi-site outpatient platforms with a mix of psychiatric prescribers and licensed therapists, at least 60% commercial insurance payer mix, documented credential panels with major commercial payers, and either Joint Commission accreditation or Behavioral Health Center of Excellence certification. Substance use disorder treatment programs and intensive outpatient programs with state licensure, Joint Commission accreditation, and commercial payer contracts regularly attract buyers at 7.0–9.0x EBITDA because of the scarcity of accredited capacity relative to demand.
Single-clinician practices or practices built primarily around one prescriber who would depart at close land at the low end (5.0–6.0x EBITDA) because the patient panel is person-dependent rather than panel-dependent. Out-of-network or self-pay-heavy practices, despite often having higher gross margin than in-network practices, are discounted by buyers because self-pay revenue is not transferable and buyers must re-credential with payers post-close at lower network rates.
Home health and home care agencies: 5.5–8.5x EBITDA
Home health and home care agencies
Home health valuation splits sharply between Medicare-certified skilled nursing home health agencies and non-certified personal care or private-duty home care businesses. The Medicare certification itself carries substantial value independent of current census: a certified agency with a clean 3-year cost report history, a risk-adjusted hospital re-admission rate below the national benchmark, and documented OASIS outcome scores at or above the state average is among the most defensible recurring revenue assets in healthcare M&A.
Medicare-certified skilled nursing home health agencies with 250 or more active census patients, employed field nurses (not 1099), and EBITDA margins above 12% consistently attract PE acquirers at 7.0–8.5x EBITDA. The CMS change of ownership application process (typically 60–90 days after sale close) cannot be accelerated, which is why home health sale timelines average 7–10 months versus 5–7 months for other sub-types. Buyers who understand this process structure it into the transaction rather than treating it as a closing obstacle.
Non-certified personal care agencies relying primarily on Medicaid waiver or private-pay revenue land at 4.5–6.5x EBITDA. The lower multiple reflects the lack of Medicare certification, higher caregiver turnover (50%+ annual turnover is common in personal care), and state Medicaid rate risk. Agencies with active Medicaid managed care contracts at favorable per-hour rates are priced at the upper portion of this range; cash-pay-only agencies that serve primarily high-net-worth private clients trade at the low end because the revenue is referral-dependent and not scalable through standard PE operational playbooks.
Urgent care centers: 5.0–8.0x EBITDA
Urgent care centers
Urgent care was the first healthcare sub-type to undergo large-scale PE consolidation, and the acquisition market is now mature. National and regional urgent care chains are the most active buyers, acquiring independent centers to add density to existing footprints and build scale advantages in payer contract negotiations. The relatively short sale timeline compared to other healthcare sub-types reflects that payer contract transfers in urgent care are typically assigned through a straightforward change-of-ownership notification rather than requiring individual provider re-credentialing for each location.
Multi-site operators (3 or more locations) with a diversified commercial payer panel, documented average daily visit volumes above 45 per site, and employed providers on standard schedules attract the strongest multiples (6.5–8.0x EBITDA). Single-site centers with below-average visit volumes land at 4.5–5.5x EBITDA, and centers with a heavy occupational health book (workers' compensation billing) at lower negotiated rates compress toward the low end of the range. Centers located in markets already served by a PE-backed urgent care chain are the most attractive acquisition targets because the buyer can fold the center into its existing managed care contracts on day one.
The COVID-era visit volume spikes that drove urgent care acquisitions at elevated multiples in 2021–2022 have normalized. Buyers in 2026 are underwriting sustainable primary care substitution visit volumes, not testing volume, and applying normalized EBITDA adjustments to remove pandemic-era revenue anomalies. Sellers should expect buyers to build a 3-year normalized EBITDA bridge as part of the LOI-stage diligence package.
Primary care and physician group practices: 3.5–6.5x EBITDA
Primary care and physician group practices
Primary care and physician group acquisitions typically involve management services organization (MSO) structures where a non-physician entity acquires the management and administrative functions while the physician group retains the clinical practice entity under state corporate practice of medicine doctrine. This structure adds legal complexity and is one reason physician practice acquisitions run 6–10 months even for smaller transactions.
Practices at the upper end of the range (5.5–6.5x EBITDA) have physicians on multi-year W-2 employment agreements with market-rate productivity compensation rather than revenue-sharing arrangements, a documented active patient panel of 2,000 or more patients per full-time equivalent physician, commercial payer mix above 55%, and recurring visit patterns from a capitated or value-based care contract that provide revenue predictability independent of individual physician production. PE-backed MSO platforms building density in concierge or direct primary care models sometimes pay above 6.5x EBITDA for practices that fit their specific network architecture.
Solo physician practices where the physician owner is also the sole clinical provider consistently land at the low end (3.5–4.5x EBITDA) because the patient panel is entirely person-dependent. Practices with significant 1099 physician arrangements, revenue-sharing compensation structures that would need to be restructured under Stark Law post-close, or active OIG or state medical board compliance issues are discounted further or structured as asset-only transactions. The Stark Law and Anti-Kickback Statute constraints on physician compensation post-close are a real transaction risk that specialized healthcare M&A advisors navigate as part of structuring every physician practice deal.
What drives a healthcare practice above or below its sub-type range
Within any sub-type, the practice's position in the range reflects the same fundamental question buyers ask in every M&A transaction: how much of this revenue survives the ownership transfer, and at what margin?
- Payer mix. Commercial insurance reimbursement rates are typically 1.5–2.5x the Medicare rate for identical services. A practice with 65% commercial payer mix earns materially more EBITDA on the same visit volume than one with 65% Medicare. Buyers model payer mix explicitly when projecting post-close revenue.
- Physician and clinician employment structure. W-2 employees with non-compete and non-solicitation agreements signal that the revenue will persist after the owner departs. Independent contractors or physician-owners with no post-close commitment give buyers less certainty, and that uncertainty is priced into the offer.
- Referral source diversity. A practice where 40% of new patient volume comes from one referring physician or one hospital system has a single point of failure buyers discount explicitly. Documented referral diversity across 10 or more sources is a premium signal.
- Multi-site scale. PE platforms are building scalable platforms, not managing individual practices. A practice with 3 or more locations is a platform asset; a single-location practice is an add-on. Platform assets trade at meaningful premiums over add-ons in the same sub-type.
- Accreditation and regulatory cleanliness. Joint Commission accreditation, NCQA recognition, or equivalent third-party quality validation signals operational maturity. An OIG exclusion list hit, active CMS recoupment, or state licensure action compresses the multiple and can kill a process entirely.
- EBITDA margin vs. sub-type benchmark. A physical therapy practice with a 22% EBITDA margin signals operational efficiency well above the industry norm; one at 10% signals staffing or billing problems buyers will diligence aggressively and price into the offer.
Payer mix: the single most important variable
Payer mix deserves its own section because it works differently in healthcare than in other industries. In most businesses, the revenue base is reasonably assumed to transfer to a new owner. In healthcare, payer contracts contain change-of-ownership provisions that require notification, and in some cases affirmative re-enrollment, of the acquiring entity. Commercial payers, Medicare, and Medicaid all treat this differently.
Commercial payer contracts typically include a clause permitting assignment to a successor entity with 30–90 days written notice. The key risk is that the payer can exercise a right to terminate or renegotiate rates at the assignment, particularly if the acquiring entity already has a separate contract at lower rates with that payer. Healthcare M&A advisors with experience in a specific sub-type know which payers in which markets have exercised this right historically and structure the timing of the payer notification accordingly.
Medicare requires a change-of-ownership notification via the PECOS system and new provider enrollment for any entity change. The CMS processing timeline of 45–90 days after close creates a period of billing disruption that buyers model as a working capital requirement. Practices that maintain clean Medicare enrollment records and respond promptly to CMS re-validation requests reduce this risk meaningfully. Medicaid is state-administered and the most variable: some state Medicaid programs require full re-enrollment of the acquiring entity, which can take 3–6 months and creates the most significant revenue bridge risk in a healthcare practice acquisition.
Physician employment structure and Stark Law considerations
The Physician Self-Referral Law (Stark Law) prohibits physicians from referring Medicare patients for designated health services to entities with which the physician has a direct financial relationship, unless the arrangement fits a defined statutory exception. In practice, this means that any post-close physician compensation structure in a Medicare-participating practice must fit into an enumerated Stark exception, most commonly the Bona Fide Employment exception or the Personal Services Arrangements exception.
The practical effect on valuation is that physician compensation cannot be structured as a revenue share that varies with the physician's own referral volume. Buyers who acquire physician practices must pay market-rate W-2 compensation regardless of the production model in place pre-close. For high-producing physicians who were previously keeping 85–95% of their collections in a solo or small group practice, the transition to a market-rate employed compensation model (typically 30–45% of collections for a primary care physician) represents a significant post-close earnings reduction that can drive physician departure risk. Buyers price this risk directly, which is why physician retention commitments negotiated before close are the most important single factor in physician practice valuations above $5M EV.
Sale timelines and credentialing considerations
Healthcare practice sales run 5–10 months from advisor engagement to funded close. The credentialing and payer transfer requirements create a minimum timeline that cannot be compressed by a faster legal process or a motivated buyer. Sellers who understand this structure their pre-sale preparation around it.
The most common timeline extension is delayed Medicare PECOS enrollment processing. CMS PECOS processing times fluctuate seasonally and have run as long as 120 days during high-volume periods. Practices that maintain current PECOS enrollment records, respond immediately to CMS re-validation requests, and keep all provider credentialing current before going to market reduce this risk. The second most common extension is Joint Commission re-accreditation notification timing: accredited behavioral health practices must notify JCAHO of the change-of-ownership at least 30 days before close, and the JCAHO review of the successor entity's accreditation eligibility can take an additional 30–60 days.
Sellers preparing for a healthcare practice sale 12–24 months before launch should focus on: transitioning 1099 clinical staff to W-2 employment, executing multi-year employment agreements with key clinical staff, diversifying referral sources, cleaning up payer contract files with complete documentation of expiration dates and assignment provisions, and addressing any open CMS compliance or state licensure items before the diligence process begins. A proactive advisor engagement before formally launching the sale process to identify and resolve these items is standard practice in healthcare M&A and consistently shortens both the timeline and the diligence-stage renegotiation risk.
Know your healthcare practice's value before you talk to a buyer
ProCloser matches healthcare practice owners with advisors who have closed transactions in your specific sub-type. The matching process is free and takes under 10 minutes.
Get Matched to a Healthcare M&A AdvisorFrequently asked questions
What are typical healthcare practice valuation multiples?
Healthcare practice valuation multiples in 2026 range from 3.5–6.5x EBITDA for primary care and physician group practices to 5.0–9.0x EBITDA for behavioral health practices with commercial insurance contracts. Physical therapy practices typically sell for 4.0–6.5x EBITDA, home health agencies for 5.5–8.5x EBITDA, and urgent care centers for 5.0–8.0x EBITDA. The sub-type and payer mix are the two strongest drivers of where a healthcare practice lands within any given range. Practices with commercial insurance revenue above 55% of total consistently earn multiples at or near the top of their sub-type range.
What is a physical therapy practice worth?
A physical therapy practice typically sells for 4.0–6.5x EBITDA in 2026. Multi-site practices with documented referral diversity across 5 or more orthopedic and sports medicine sources, W-2 employed therapists with non-compete agreements, and EBITDA margins above 18% attract PE platform buyers at 5.5–6.5x EBITDA. Single-location owner-operated PT practices where the owner is also the primary treating therapist land at 3.5–4.5x EBITDA. The biggest single discount factor is therapist concentration: when revenue depends substantially on the departing owner-therapist, buyers price that transition risk directly into the offer.
What EBITDA multiple does a behavioral health practice sell for?
Behavioral health and mental health practices sell for 5.0–9.0x EBITDA in 2026, the widest range in healthcare practice M&A. A single-clinician outpatient therapy practice lands at 5.0–6.5x EBITDA. A multi-site platform with psychiatric prescribers, group therapy programs, and documented commercial payer contracts earns 7.5–9.0x EBITDA. Substance use disorder treatment programs with Joint Commission accreditation and commercial insurance payer mix attract the top of the range. Payer mix is the decisive variable: commercial insurance payer mix above 60% consistently produces the strongest multiples.
How much is a home health agency worth?
Home health agencies typically sell for 5.5–8.5x EBITDA in 2026. Medicare-certified skilled nursing home health agencies with 250 or more active census patients and EBITDA margins above 12% attract PE buyers at 7.0–8.5x EBITDA. Non-certified personal care or private-duty agencies land at 4.5–6.5x EBITDA. The Medicare certification carries substantial value independent of current census. The CMS change of ownership application process adds 60–90 days to the sale timeline and must be planned for in advance.
How does payer mix affect healthcare practice valuation?
Payer mix is the single strongest multiple driver across all healthcare practice sub-types. Commercial insurance reimbursement rates are typically 1.5–2.5x the Medicare rate for identical services. Practices with 60% or more commercial payer mix earn materially higher EBITDA margins on the same visit volume as Medicare-heavy practices, and buyers project payer mix at the letter-of-intent stage. Medicaid-dependent practices face the most scrutiny because Medicaid rates are set legislatively and subject to clawback. Multi-year payer contract renewals with documented assignment rights are the most important single pre-sale improvement a healthcare practice owner can make to maximize valuation.
Does physician employment structure affect valuation?
Yes, significantly. W-2 employed physicians with non-compete and non-solicitation agreements are far easier for buyers to underwrite than 1099 contractor physicians with no post-close commitment. Practices that have transitioned key clinical staff to W-2 employment and secured multi-year employment agreements before launching a sale process consistently earn stronger multiples and close with fewer last-minute renegotiations. The Stark Law requires that all physician compensation in a Medicare-participating practice post-close fit a defined statutory exception, which means revenue-sharing arrangements must be restructured before or at close.
What buyers are most active in healthcare practice M&A?
PE-backed platform roll-ups are the dominant buyer above $2M EBITDA across physical therapy, behavioral health, and home health. Regional health systems acquire practices for patient capture and referral network expansion. PE MSO platforms are active in primary care, often structured through a management services organization to comply with state corporate practice of medicine laws. Urgent care chains acquire independent centers to build payer contract negotiating scale. The buyer category determines the multiple ceiling: a PE platform already operating in your geography and seeking density is the highest-price buyer available, and identifying that platform before beginning a process is the core value of a specialized healthcare M&A advisor.
How long does it take to sell a healthcare practice?
Most healthcare practice sales close in 5–10 months from advisor engagement to funded close. Credentialing and payer contract transfer requirements create a minimum timeline: Medicare PECOS enrollment processing takes 45–90 days post-close, Medicaid re-enrollment in some states can take 3–6 months, and Joint Commission re-accreditation notifications add 30–60 days for accredited behavioral health practices. Sellers who begin credentialing preparation 6–12 months before going to market, maintain current PECOS enrollment, and document payer contract assignment provisions in advance consistently close at the lower end of their deal-size range timeline.
Disclosure
The multiples on this page are indicative ranges compiled from publicly reported healthcare M&A transaction data, HFMA industry benchmarks, Irving Levin healthcare deal reports, and broker-published lower-middle-market healthcare transaction data for the period 2024–2026. They reflect transactions in the lower-middle market ($1M–$15M EBITDA). Actual valuation depends on specific practice characteristics, market conditions, buyer competition, and deal structure. This is not legal, financial, or regulatory advice. Healthcare M&A transactions involve complex regulatory requirements including Stark Law, Anti-Kickback Statute, state corporate practice of medicine laws, and CMS change-of-ownership requirements; consult qualified healthcare M&A legal counsel before beginning a sale process.